PETROS PHARM INC by Petros Pharmaceuticals, Inc. (PTPI) Stock Price Target 2026

The average analyst price target for PETROS PHARM INC by Petros Pharmaceuticals, Inc. is $100, 3225706.5% above the current price. The one analyst covering it rates it Buy. The latest change came on Dec 8, 2023, when Maxim Group initiated coverage of PETROS PHARM INC by Petros Pharmaceuticals, Inc. with a Buy rating and a $100 price target.